CLINICOPATHOLOGICAL FACTORS ASSOCIATED WITH EXTRATHYROIDAL EXTENSION IN PAPILLARY THYROID CARCINOMA

Annals of Research in Oncology · Published 2026-06-01 · DOI 10.48286/aro.2026.127

Authors (3)

N.Q. Dang, K.V. Vo, K.A. Nguyen

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Dang, N., Vo, K., Nguyen, K. (2026). CLINICOPATHOLOGICAL FACTORS ASSOCIATED WITH EXTRATHYROIDAL EXTENSION IN PAPILLARY THYROID CARCINOMA. Annals of Research in Oncology. https://doi.org/10.48286/aro.2026.127

Related articles

• SARCOMATOID CARCINOMA OF THE PROSTATE – RARE ENTITY WITH RARE PRESENTATION: A CASE REPORT · Annals of Research in Oncology · 2026 · Same journal
• Perspectives and innovation in pediatric psycho-oncology: research, advanced therapies, technologies and new frontiers · Annals of Research in Oncology · 2024 · Same journal
• RESPONSES DURING COGNITIVE STRESS TEST FOR AUTOMATIC PAIN ASSESSMENT IN CANCER PATIENTS · Annals of Research in Oncology · 2025 · Same journal
• GIANT RETROPERITONEUM SCHWANNOMA CAUSING IPSILATERAL HYDRONEPHROSIS: A RARE CASE REPORT · Annals of Research in Oncology · 2026 · Same journal
• TRENDS, CLINICOPATHOLOGIC FEATURES, AND MANAGEMENT OF IN SITU BREAST CANCER: INSIGHTS FROM THE NORTH ITALY CANCER REGISTRY, 2000-2023 · Annals of Research in Oncology · 2026 · Same journal
• ERBB2 VARIANTS DISTRIBUTION IN NON-SMALL CELL LUNG CANCER: AN ITALIAN REAL-WORLD EXPERIENCE · Annals of Research in Oncology · 2023 · Same journal
• Survival and mortality of kidney cancer in relation to cardiovascular diseases and treatments · Annals of Research in Oncology · 2025 · Same journal
• Aflibercept plus FOLFIRI as second-line therapy in metastatic colorectal cancer (mCRC) during pandemic COVID-19: a real-world experience · Annals of Research in Oncology · 2024 · Same journal
• ‘THEY ARE RARE, BUT THEY ARE THERE’. REPORT FROM THE GYNOCARE TRAINING SCHOOL IN SOFIA, BULGARIA (29TH JUNE-1ST JULY 2023) · Annals of Research in Oncology · 2023 · Same journal
• MORE VOICE FOR PATIENTS WITH ENDOMETRIAL CARCINOMA: esprimEndo POLICY STATEMENT · Annals of Research in Oncology · 2025 · Same journal